UBS Group AG grew its position in Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Rating) by 244.5% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,302,576 shares of the company’s stock after acquiring an additional 924,421 shares during the period. UBS Group AG owned 4.80% of Tabula Rasa HealthCare worth $6,448,000 at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of the company. Envestnet Asset Management Inc. raised its stake in shares of Tabula Rasa HealthCare by 12.0% in the first quarter. Envestnet Asset Management Inc. now owns 43,874 shares of the company’s stock valued at $253,000 after acquiring an additional 4,691 shares during the last quarter. Teramo Advisors LLC raised its stake in shares of Tabula Rasa HealthCare by 25.0% in the fourth quarter. Teramo Advisors LLC now owns 25,000 shares of the company’s stock valued at $124,000 after acquiring an additional 5,000 shares during the last quarter. Teachers Retirement System of The State of Kentucky bought a new position in Tabula Rasa HealthCare in the 3rd quarter worth approximately $25,000. Swiss National Bank raised its position in Tabula Rasa HealthCare by 10.9% in the 1st quarter. Swiss National Bank now owns 57,800 shares of the company’s stock worth $333,000 after purchasing an additional 5,700 shares during the last quarter. Finally, Mattern Capital Management LLC raised its position in Tabula Rasa HealthCare by 27.9% in the 3rd quarter. Mattern Capital Management LLC now owns 36,323 shares of the company’s stock worth $174,000 after purchasing an additional 7,920 shares during the last quarter. Institutional investors own 60.90% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on TRHC. SVB Leerink upgraded shares of Tabula Rasa HealthCare from a “market perform” rating to an “outperform” rating in a research report on Wednesday, May 10th. SVB Securities raised shares of Tabula Rasa HealthCare from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $7.00 to $10.00 in a report on Wednesday, May 10th. StockNews.com assumed coverage on shares of Tabula Rasa HealthCare in a report on Thursday, May 18th. They set a “hold” rating for the company. Finally, Piper Sandler lifted their target price on shares of Tabula Rasa HealthCare from $4.00 to $6.00 in a report on Friday, March 10th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. Based on data from MarketBeat.com, Tabula Rasa HealthCare currently has a consensus rating of “Hold” and a consensus target price of $6.63.
Tabula Rasa HealthCare Price Performance
Tabula Rasa HealthCare (NASDAQ:TRHC – Get Rating) last announced its quarterly earnings results on Monday, March 6th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.10) by ($0.12). Tabula Rasa HealthCare had a negative net margin of 42.17% and a negative return on equity of 472.90%. The firm had revenue of $82.71 million during the quarter, compared to analyst estimates of $82.53 million. Equities analysts predict that Tabula Rasa HealthCare, Inc. will post -0.91 EPS for the current fiscal year.
About Tabula Rasa HealthCare
Tabula Rasa Healthcare, Inc is a healthcare technology company, which engages in the development of solutions designed for pharmacists, providers, and patients to optimize medication regimens. It operates through the following segments: CareVention HealthCare and MedWise HealthCare. The CareVention HealthCare segment provides services, PACE, which is a center for Medicare & Medicaid services, or CMS, sponsored program providing medical and social services.
- Get a free copy of the StockNews.com research report on Tabula Rasa HealthCare (TRHC)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Want to see what other hedge funds are holding TRHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC – Get Rating).
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.